Hanmi Pharmaceutical Company Limited
Clinical trials sponsored by Hanmi Pharmaceutical Company Limited, explained in plain language.
-
New combo therapy shows promise for tough stomach cancers
Disease control CompletedThis study tested a new drug (FLX475) combined with an immunotherapy (pembrolizumab) in 20 people with advanced or metastatic stomach cancer who had already tried other treatments. The goal was to see if the combination could shrink tumors. Participants were split into two groups…
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New back pain drug shows promise in large trial
Symptom relief CompletedThis study tested a new medicine called HCP1004 against an existing one (RLD2401) in 310 adults with chronic low-back pain lasting at least 3 months. The goal was to see if the new drug works just as well and is safe. Participants rated their pain on a scale, and researchers also…
Phase: PHASE3 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Symptom relief
Last updated May 17, 2026 04:17 UTC